The Business Research Company offers electronic drug delivery systems market research report 2023 with industry size, share, segments and market growth
Increase in prevalence of target diseases including diabetes, asthma, chronic obstructive pulmonary disorder (COPD), and cardiovascular diseases coupled with rapid technological advancements in drug delivery devices are key factors driving the global electronic drug delivery systems market.
The global transdermal drug delivery systems market size reached US$ 6.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.36% during 2022-2027. More info: https://www.imarcgroup.com/transdermal-drug-delivery-systems-market
According to the latest research report by IMARC Group, The global needle-free drug delivery technology market size reached US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.56% during 2024-2032. More Info:- https://www.imarcgroup.com/needle-free-drug-delivery-technology-market
According to the latest research report by IMARC Group, The global needle-free drug delivery technology market size reached US$ 4.18 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.72 Billion by 2028, exhibiting a growth rate (CAGR) of 5.22% during 2023-2028. More Info:- https://www.imarcgroup.com/needle-free-drug-delivery-technology-market
The increasing prevalence of autoimmune diseases among individuals and the rising number of patients suffering from SLE represents one of the major factors driving the demand for SLE drugs around the world Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/systemic-lupus-erythematosus-drugs-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The global injectable drug delivery market was valued at US$ 30.5 Bn in 2018, and is expected to exhibit a CAGR of around 9% during the forecast period (2019–2029).
The global advanced dermatology drug delivery devices market size is expected to grow from USD 3,569.8 million in 2021 to USD 8,783.0 million by 2030, at a CAGR of 10.5% from 2022 to 2030. The global advanced dermatology drug delivery devices market is driven by factors such as the global efforts in increasing the adoption of connected devices, increasing number of business synergies with pharmaceutical companies, novel technologies in drug delivery, and the growing focus on prescription/medication adherence. Manufacturers are more focused on producing devices that offer enhanced patient experience through real-time monitoring and data sharing.
Electronic Data Capture (EDC) Market size in 2020 is estimated to be $361 million, growing at a CAGR of 11.9% during the forecast period 2021-2026. The Electronic Data Capture Market system (EDC) is a computerized system designed to collect clinical data in electronic format and is primarily used in human clinical trials.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants.
The growth of the NDDS market is propelled by the rising adoption of different controlled release medications, increasing demand and recognition among physicians of advanced products, and growing prescription patterns for controlled release products.
This study offers a comprehensive, 360 degree analysis on the Ultrasound Systems market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Ultrasound Systems market across key regions, and offers in-depth commentary and accurate quantitative insights.
Adroit Market Research has announced the addition of the Global Needle Free Drug Delivery Devices Market by company, by country, and by application/type for the competitive landscape analysis.
The covid-19 pandemic have created an awareness regarding the need of automotive and robots in pharmaceutical industries. As pharmacy automation system can help in reducing the medication errors, and also reduce medication cost, its demand may have a positive impact during the forecast period. With the help of robots, labour cost can be reduced which can act as a driver for the market growth. Some of the recent developments in the industry are mentioned below.
The global transdermal drug delivery system (TDDS) market was valued at USD 5,737 million in 2020 and is projected to grow at a CAGR of 4.7% during the forecast period.
The global artificial intelligence (AI) in epidemiology market is set to grow with a 27.33% CAGR between 2024 and 2032. Get more insights into our latest blogs
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
Patient-controlled analgesic (PCA) pumps represent a crucial component in pain management, allowing patients to administer their own pain relief medication at their discretion within prescribed limits. This method provides autonomy, minimizes delays in pain relief, and aligns with individualized patient care. According to Persistence Market Research's projections, the global PCA pumps market is anticipated to grow steadily, with an estimated CAGR of 7.1%, increasing from a valuation of US$ 360 Million in 2023 to US$ 712 Million by 2033.
According to the latest research report by IMARC Group, The global aerosol delivery devices market size reached US$ 47.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 73.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032. More Info:- https://www.imarcgroup.com/aerosol-delivery-devices-market
According to the latest research report by IMARC Group, The global epilepsy drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.16% during 2024-2032. More Info:- https://www.imarcgroup.com/epilepsy-drugs-market
According to the latest research report by IMARC Group, The global pharmacovigilance and drug safety software market size reached US$ 202.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 341.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032. More Info:- https://www.imarcgroup.com/pharmacovigilance-drug-safety-software-market
Global Smart Polymers Market Information- by Stimulus Type (Physical, Chemical and Biological Responsive Polymers), by Application (Biotechnology and Medicine, Electrical & Electronics, Automotive, Drug Delivery Systems, and Others) - Forecast till 2023
According to the latest research report by IMARC Group, The global clinical decision support systems (CDSS) market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a CAGR of 6.72% during 2024-2032. More Info:- https://www.imarcgroup.com/clinical-decision-support-systems-market
According to the latest research report by IMARC Group, The global clinical decision support systems (CDSS) market size reached US$ 1.50 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.36 Billion by 2028, exhibiting a CAGR of 7.70% during 2023-2028. More info:- https://www.imarcgroup.com/clinical-decision-support-systems-market
According to the latest research report by IMARC Group, The global medical document management systems market size reached US$ 551.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,111.7 Million by 2028, exhibiting a growth rate (CAGR) of 11.9% during 2023-2028. More Info:- https://www.imarcgroup.com/medical-document-management-systems-market
Overview of Pharmacovigilance and Drug Safety Software Market Report Helps In Providing Scope and Definitions, Key Findings, Growth Drivers, and Various Dynamics.
According to the latest research report by IMARC Group, The global aerosol delivery devices market size reached US$ 44.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028. More Info:- https://www.imarcgroup.com/aerosol-delivery-devices-market
Persistence Market Research has delivered key insights and presented a revised forecast of the global sterile injectable drugs market for a period of 8 years from 2017 to 2025. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based factors driving the demand, as well as the recent developments of key market participants.
The global CMO/CDMO biotechnology market was valued at over US$ 8.3 Bn in 2020, and is expected to exhibit a CAGR of around 11% over the forecast period (2021 – 2031).
According to the latest research report by IMARC Group, The global pharmacovigilance and drug safety software market size reached US$ 189.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 283.3 Million by 2028, exhibiting a growth rate (CAGR) of 6.51% during 2023-2028. More Info:- https://www.imarcgroup.com/pharmacovigilance-drug-safety-software-market
The global aerosol delivery devices market size is projected to grow from USD 14,392.4 million in 2020 to USD 20,918.7 million by 2027, registering a CAGR of 4.9% during the forecast period from 2021 to 2027.
The electronic design automation market accounted to US$10.31 Bn in 2018 and is expected to grow at a CAGR of 12.0% during the forecast period 2019 – 2027, to account to US$28.27 Bn by 2027
The market for cutaneous & systemic leishmaniasis comprises of drugs such as pentavalent antimonials and antifungal & antilesihmaniasis drugs. In the cutaneous & systemic leishmaniasis market, these drugs are available in the form of oral drugs, injectables, and topical medicines. Among all the products, antifungal drugs are considered to be a major revenue-generating drug class in the cutaneous & systemic leishmaniasis market.
There are varied Single Use Technology products like filling and tubing systems, cell culture apparatus, petri plates, flasks, cell culture apparatus, filters, bioreactors, pumps which are used in the biopharmaceutical industry. Single-use technologies are is prominently used in biopharmaceutical manufacturing processes. These Single-use technologies will facilitate the advancements of small amounts of drugs for preclinical and clinical testing processes.
The global pharmacovigilance and drug safety software market reached a value of US$ 176.6 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 265 Million by 2027 exhibiting a CAGR of 6.60% during 2022-2027. More info:- https://www.imarcgroup.com/pharmacovigilance-drug-safety-software-market
The global pharmacovigilance and drug safety software market reached a value of US$ 176.6 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 265 Million by 2027 exhibiting a CAGR of 6.60% during 2022-2027. More info:- https://www.imarcgroup.com/pharmacovigilance-drug-safety-software-market
Are current methods used for measuring drug levels in blood and tissues adequate ... from drug exposure, due to the extensive pre-clinical evaluation of new drugs. ...
Medical electronics market size is anticipated to reach USD 60 billion by 2023 growing at a CAGR of over 5.5% from 2016 to 2023. Rapid urbanization and increasing healthcare facilities is expected to drive the industry growth.
Voice Activated Systems and Electronic Medical Records Gary P. Kearney MD FACS Medisense http://208.146.137.27/ Appointment Scheduling Anesthesia Management Medical ...
Medical electronics market size is anticipated to reach USD 60 billion by 2023 growing at a CAGR of over 5.5% from 2016 to 2023. Rapid urbanization and increasing healthcare facilities is expected to drive the industry growth.
Looking forward, the diabetes drugs and diagnostics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/diabetes-drugs-diagnostics-market
Carpal Tunnel Release Systems Market 2019 Analysis and Review of Carpal Tunnel Release Systems Market by Product - Open CTR Systems and Endoscopic CTR Systems for 2019 - 2029
“The global sterile injectable drugs market will potentially achieve the revenues worth US$ 657 Bn by the end of 2024. With a compound annual growth rate of more than 7%, the market is expected to experience promising growth prospects over an eight-year forecast period, 2016-2024.”
The growth of the psoriasis drugs market is attributed to the growing use of topical corticosteroids products and psoriasis treatment across the globe. According to a latest research by the company, the global corticosteroid psoriasis drugs treatment market is expected to account for over US$ 6,509 Mn in terms of value by 2028 end.
In the report, titled “Medical Oxygen Systems Market: Global Industry Analysis and Forecast, 2016-2024,” Persistence Market Research projects that North America will exhibit its dominance in the global medical oxygen system market by accounting for more than 35% revenue share by end of assessment period.
Electroactive Polymers Market Overview: The global electro-active polymers market is expected to exhibit a CAGR of over 7% during the review period. The growing industrialization and urbanization in the developing regions across the globe are expected to boost the market growth during the forecast years. Moreover, the growing demand from the automobile and electronics sector among others is further anticipated to contribute to the growth of the segment. Free Sample Request Report Here @ https://www.marketresearchfuture.com/sample_request/5665
Growth of the medical pouch inspection systems market is highly proportional to the growth of the pharmaceutical industry. As per FMI analysis, at a global level, the medical pouch inspection systems market is expected to remain at a strong position.